|Benefit-Cost Summary Statistics Per Participant|
|Taxpayers||$3,686||Benefits minus costs||$11,271|
|Participants||$7,282||Benefit to cost ratio||$25.26|
|Others||$668||Chance the program will produce|
|Indirect||$100||benefits greater than the costs||87 %|
|Net program cost||($465)|
|Benefits minus cost||$11,271|
|Meta-Analysis of Program Effects|
|Outcomes measured||Treatment age||No. of effect sizes||Treatment N||Adjusted effect sizes(ES) and standard errors(SE) used in the benefit - cost analysis||Unadjusted effect size (random effects model)|
|First time ES is estimated||Second time ES is estimated|
Clinical diagnosis of an anxiety disorder (e.g., general anxiety, panic, social anxiety, obsessive compulsive disorder) or symptoms measured on a validated scale.
Major depressive disorder^^
Clinical diagnosis of major depression or symptoms measured on a validated scale.
|Detailed Monetary Benefit Estimates Per Participant|
|Affected outcome:||Resulting benefits:1||Benefits accrue to:|
|Anxiety disorder||K-12 grade repetition||$16||$0||$0||$8||$25|
|Labor market earnings associated with anxiety disorder||$3,022||$7,099||$0||$0||$10,122|
|Health care associated with anxiety disorder||$647||$183||$668||$324||$1,822|
|Program cost||Adjustment for deadweight cost of program||$0||$0||$0||($232)||($232)|
|Detailed Annual Cost Estimates Per Participant|
|Annual cost||Year dollars||Summary|
|Program costs||$1,585||2016||Present value of net program costs (in 2018 dollars)||($465)|
|Comparison costs||$1,144||2016||Cost range (+ or -)||20 %|
Benefits Minus Costs
Benefits by Perspective
Taxpayer Benefits by Source of Value
|Benefits Minus Costs Over Time (Cumulative Discounted Dollars)|
|The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment.|
Bolton, D., & Perrin, S. (2008). Evaluation of exposure with response-prevention for obsessive compulsive disorder in childhood and adolescence. Journal of Behavior Therapy and Experimental Psychiatry, 39, 11-22.
Lewin, A.B., Park, J.M., Jones, A.M., Crawford, E .A., De Nadai, A.S., Menzel, J., . . . Storch, E.A. (2014). Family-based exposure and response prevention therapy for preschool-aged children with obsessive-compulsive disorder: A pilot randomized controlled trial. Behavior Research and Therapy, 56,30-38.
Simons, M., Schneider, S., & Herpertz-Dahlmann, B. (2006). Metacognitive therapy versus exposure and response prevention for pediatric obsessive-compulsive disorder. Psychotherapy and Psychosomatics, 75, 257-264.